Belgium· BE-AMP-SAM366405-00

Urorec 8 mg

A silodosin product containing silodosin, registered in Belgium by Recordati Ireland. The same ATC class is registered in 17 of our 19 countries.

ATC G04CA04

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about silodosinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Silodosin is registered in 17 of 19 countries.

Countries holding a registration under ATC G04CA04 (silodosin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search silodosin products by name

Silodosin · ATC G04CA04

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of silodosin costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $0.28 in Italy to $1.39 in Switzerland — a ×5.0 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Silodosin · price per daily dose (8 mg)

USD · FX 28 Sept 2026

CH Switzerland$1.39
IT Italy$0.28

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Silodosin
Manufacturer: Recordati Ireland
Country: Belgium (BE)
ATC code: G04CA04
ATC class: Silodosin
Defined daily dose: 8 mg, O
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

148 interactions on record for silodosin.

Graded by severity as the source publishes them — 9 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check silodosin against other medicines How interaction checks work

Silodosin · interactions on record

148 records

9 severe
139 moderate

Most severe, free to view

KetoconazoleH02CA03severe
ClarithromycinJ01FA09severe
KetoconazoleJ02AB02severe
Darunavir and cobicistatJ05AR14severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Silodosin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All silodosin products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

Bulgaria · Пирсео, Сидарсо
Germany · Silbesan, Silodosin Al
Spain · Silodosina Abamed, Silodosina Alter
France · Silodosine Arrow, Silodosine Biogaran
Croatia · Niksol, Sidarso
Hungary · Pirseo, Sidarso
Iceland · Silodosin Recordati, Silodyx
Italy · Silodosina Aristo, Silodosina Aurobindo
Liechtenstein · Silodosin Recordati, Silodyx
Lithuania · Sidarso
Netherlands · Silodosin Aurobindo, Silodosine Amarox
Norway · Silodosin Recordati, Silodyx
Poland · Sidarso, Silodosin Aurovitas
Portugal · Silodosin Ipca, Silodosin Msn
Romania · Sidarso
Slovenia · Sidarso
Slovakia · Sidarso, Silodosin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/f017c0a6-28cf-406f-8c17-5e47f857f756
GET /v1/drugs/f017c0a6-28cf-406f-8c17-5e47f857f756?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Urorec 8 mg",
  "name_fr": "Urorec 8 mg",
  "name_nl": "Urorec 8 mg",
  "amp_code": "SAM366405-00",
  "strengths": [
    "8.0000"
  ],
  "pack_count": 7,
  "substances": [
    "Silodosin",
    "Mannitol",
    "Sodium Laurilsulfate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Silodosin",
  "authorisation_numbers": [
    "EU/1/09/608/008",
    "EU/1/09/608/010",
    "EU/1/09/608/009",
    "EU/1/09/608/012",
    "EU/1/09/608/011",
    "EU/1/09/608/014",
    "EU/1/09/608/013"
  ]
}

API reference MCP server Plans

See everything about silodosin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console